Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

Blood

Volumn 100, Issue 2, 2002, Pages 627-634

  McKallip, Robert J ^a   Lombard, Catherine ^a   Fisher, Michael ^a   Martin, Billy R ^a   Ryu, Seongho ^a   Grant, Steven ^a   Nagarkatti, Prakash S ^a   Nagarkatti, Mitzi ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; DEXANABINOL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MASTOCYTOMA; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

EID: 0037100312     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0098     Document Type: Article

References (36)

1. Cannabinoid receptors and the regulation of immune response
2. Marijuana and medicine: Assessing the science base: A summary of the 1999 Institute of Medicine report
3. Determination and characterization of a cannabinoid receptor in rat brain
4. Molecular characterization of a peripheral receptor for cannabinoids
5. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
6. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction
7. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
8. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
9. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells
10. Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism
11. Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation
12. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
13. Inhibition of glioma growth in vivo by selective activation of the cb(2) cannabinoid receptor
14. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8- tetrachlorodibenzo-p-dioxin in vivo
15. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection; evidence for involvement of CD44 in activation-induced cell death
16. Serum proteins affect the inhibition by delta-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse macrophages
17. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability
18. Anandamide induces apoptosis in human cells via vanilloid receptors: Evidence for a protective role of cannabinoid receptors
19. Anandamide induces apoptosis of PC-12 cells: Involvement of superoxide and caspase-3
20. Pharmacology of cannabinoid receptor ligands
21. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
22. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist
23. The cannabinoid system and cytokine network
24. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): A putative mechanism of cannabinoid-induced immune modulation
25. Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system
26. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid
27. Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: Molecular basis of costimulation
28. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
29. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2
30. Control of CD4 effector fate: Transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion
31. Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells
32. Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin
33. Pharmacology of cannabinoid CB1 and CB2 receptors
34. Cannabinoid receptors and immunity
35. Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice
36. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes